Association Between Preadmission Acid Suppressive Medication Exposure and Severity of Illness in Patients Hospitalized With COVID-19.

Elmunzer, B Joseph; Wolf, Bethany J; Scheiman, James M; Tierney, William M; Taylor, Jason R

Elmunzer, B Joseph; Wolf, Bethany J; Scheiman, James M; Tierney, William M; Taylor, Jason R.

Elmunzer BJ; Division of Gastroenterology and Hepatology, Medical University of South Carolina, Charleston, South Carolina. Electronic address: elmunzer@musc.edu.
Wolf BJ; Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina.
Scheiman JM; Division of Gastroenterology, University of Virginia Medical School, Charlottesville, Virginia.
Tierney WM; Section of Digestive Diseases and Nutrition, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Taylor JR; Division of Gastroenterology and Hepatology, Saint Louis University, St. Louis, Missouri.

Gastroenterology ; 160(4): 1417-1422.e14, 2021 Mar.

Article in English | MEDLINE | ID: covidwho-1046005

Subject(s)

COVID-19/complications; Histamine H2 Antagonists/adverse effects; Proton Pump Inhibitors/adverse effects; SARS-CoV-2; Adult; Aged; COVID-19/mortality; Female; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Severity of Illness Index

Keywords

COVID-19; Histamine 2 Receptor Antagonists; Proton Pump Inhibitor; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Proton Pump Inhibitors / SARS-CoV-2 / COVID-19 / Histamine H2 Antagonists Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Gastroenterology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google